|
|
Volumn 38, Issue 2, 2015, Pages e15-e17
|
|
Treatmentwith the dipeptidyl peptidase-4 inhibitor linagliptin or placebo followed by glimepiride in patients with type 2 diabetes with moderate to severe renal impairment: A 52-week, randomized, double-blind clinical trial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLIMEPIRIDE;
GLUCOSE;
HEMOGLOBIN A1C;
INSULIN;
LINAGLIPTIN;
PLACEBO;
ANTIDIABETIC AGENT;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
GLYCOSYLATED HEMOGLOBIN;
PURINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
SULFONYLUREA DERIVATIVE;
AGED;
ARTICLE;
BLOOD GLUCOSE MONITORING;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
FEMALE;
GLOMERULUS FILTRATION RATE;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HEART FAILURE;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPOGLYCEMIA;
KIDNEY DISEASE;
MAJOR CLINICAL STUDY;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
RANDOMIZED CONTROLLED TRIAL;
SELF MONITORING;
BLOOD;
CHEMICALLY INDUCED;
CLINICAL TRIAL;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
DRUG COMBINATION;
METABOLISM;
MULTICENTER STUDY;
AGED;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
DOUBLE-BLIND METHOD;
DRUG THERAPY, COMBINATION;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIA;
HYPOGLYCEMIC AGENTS;
MALE;
PURINES;
QUINAZOLINES;
SULFONYLUREA COMPOUNDS;
|
|
EID: 84921908680
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc14-1684 Document Type: Article |
|
Times cited : (43)
|
|
References (4)
|
